Stemcell101.com
  • Home
  • About Us
    • About Us
    • Causes We Support
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
Select Page

Solent student masters the art of fake wounds to create life-saving simulations for the military and NHS

by rss feed | Jun 13, 2026 | News Feeds

A Southampton Solent University student is set to graduate with two jobs already secured, one with the Ambulance Service and one delivering trauma simulation training for the British military. Read Original...

Noninvasive sequencing expands prenatal genetic screening capabilities

by rss feed | Jun 13, 2026 | News Feeds

While non-invasive prenatal testing (NIPT) has revolutionised prenatal diagnostics by allowing the detection of a number of genetic problems in a fetus, it is currently limited and thus misses many genetic causes of abnormalities. Read Original...

Trauma-related conditions drive deaths in women with HIV

by rss feed | Jun 13, 2026 | News Feeds

Women with HIV most often die from preventable, trauma-related conditions like substance use and mental illness - not the virus itself. Yet, these leading causes are largely missing from official death records, according to new research by UC San Francisco. Read...

Researchers identify vulnerabilities shared by surviving cancer cells

by rss feed | Jun 13, 2026 | News Feeds

Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These "persister" cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment. Read Original...

FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk

by rss feed | Jun 13, 2026 | News Feeds

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of...

Renowned physician‑scientist to lead Houston Methodist’s cell and gene therapy research

by rss feed | Jun 13, 2026 | News Feeds

Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has been tapped to lead the newly formed Houston Methodist Center for Cell and Gene Therapy. Read Original...
« Older Entries

Quick Navigation

  • Home
  • Stem Cell Info
    • Stem Cell Research
    • Stem Cell Applications
    • Health and Beauty
    • Pets / Animals
    • Nutrition
    • Stem Cell Blogs
    • A Stem Cell Story
  • Health Care Directory
  • Contact Us
  • About Us
    • About Us
    • Causes We Support

RSS Recent Post

Sign up for StemCell101.com Mailing List

By subscribing to our mailing list, you will get the latest news from us.